Literature DB >> 20960104

MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas.

Gail Stilling1, Zhifu Sun, Shuya Zhang, Long Jin, Alberto Righi, Gábor Kovācs, Márta Korbonits, Bernd W Scheithauer, Kalman Kovacs, Ricardo V Lloyd.   

Abstract

MicroRNAs (miRNAs) are involved in cell proliferation, differentiation, and apoptosis, and can function as tumor suppressor genes or oncogenes. The expression of miRNAs in pituitary carcinomas has not been previously examined. We used miRNA profiling with 1,145 probes to study miRNA expression in normal anterior pituitary (6 cases), adrenocorticotropin (ACTH)-producing adenomas (8 cases), and ACTH-producing pituitary carcinomas (two cases). Real-time RT-PCR and in situ hybridization were used to confirm and independently validate miRNAs that were significantly up-regulated or down-regulated between the pituitary tissues. There were more miRNAs up- (188) or down-regulated (160) between adenomas and normal pituitaries compared to carcinomas and normal pituitaries (92 up- and 91 down-regulated) or between carcinomas and adenomas (46 up- and 52 down-regulated). Both real-time RT-PCR and in situ hybridization showed significant up-regulation of miRNA-122 between pituitary carcinomas and adenomas. MiRNA-493 was also up-regulated in carcinomas compared to ACTH adenomas. Analysis of genes that miRNA-493 interacts with included LGALS3 and RUNX2 ( http://microrna.sanger.ac.uk ) both of which have been shown to have roles in pituitary tumor cell growth. These results provide information about marker miRNAs that may lead to further insights into the regulation of pituitary tumor growth and development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20960104     DOI: 10.1007/s12020-010-9346-0

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  35 in total

1.  Faster cyclic loess: normalizing RNA arrays via linear models.

Authors:  Karla V Ballman; Diane E Grill; Ann L Oberg; Terry M Therneau
Journal:  Bioinformatics       Date:  2004-05-27       Impact factor: 6.937

2.  Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas.

Authors:  Arianna Bottoni; Maria Chiara Zatelli; Manuela Ferracin; Federico Tagliati; Daniela Piccin; Cristina Vignali; George A Calin; Massimo Negrini; Carlo M Croce; Ettore C Degli Uberti
Journal:  J Cell Physiol       Date:  2007-02       Impact factor: 6.384

3.  RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain.

Authors:  Peter T Nelson; Don A Baldwin; Wigard P Kloosterman; Sakari Kauppinen; Ronald H A Plasterk; Zissimos Mourelatos
Journal:  RNA       Date:  2005-12-22       Impact factor: 4.942

Review 4.  A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes.

Authors:  O A Kent; J T Mendell
Journal:  Oncogene       Date:  2006-10-09       Impact factor: 9.867

5.  Identification of tissue-specific microRNAs from mouse.

Authors:  Mariana Lagos-Quintana; Reinhard Rauhut; Abdullah Yalcin; Jutta Meyer; Winfried Lendeckel; Thomas Tuschl
Journal:  Curr Biol       Date:  2002-04-30       Impact factor: 10.834

6.  A microRNA polycistron as a potential human oncogene.

Authors:  Lin He; J Michael Thomson; Michael T Hemann; Eva Hernando-Monge; David Mu; Summer Goodson; Scott Powers; Carlos Cordon-Cardo; Scott W Lowe; Gregory J Hannon; Scott M Hammond
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

7.  miR-15a and miR-16-1 down-regulation in pituitary adenomas.

Authors:  Arianna Bottoni; Daniela Piccin; Federico Tagliati; Andrea Luchin; Maria Chiara Zatelli; Ettore C degli Uberti
Journal:  J Cell Physiol       Date:  2005-07       Impact factor: 6.384

8.  MicroRNAs differentially expressed in ACTH-secreting pituitary tumors.

Authors:  Fernando Colbari Amaral; Natalia Torres; Fabiano Saggioro; Luciano Neder; Hélio Rubens Machado; Wilson Araújo Silva; Ayrton Custódio Moreira; Margaret Castro
Journal:  J Clin Endocrinol Metab       Date:  2008-10-07       Impact factor: 5.958

9.  RUNX1 and RUNX2 upregulate Galectin-3 expression in human pituitary tumors.

Authors:  He-Yu Zhang; Long Jin; Gail A Stilling; Katharina H Ruebel; Kendra Coonse; Yoshinori Tanizaki; Avraham Raz; Ricardo V Lloyd
Journal:  Endocrine       Date:  2008-11-20       Impact factor: 3.633

10.  MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.

Authors:  Shoumei Bai; Mohd W Nasser; Bo Wang; Shu-Hao Hsu; Jharna Datta; Huban Kutay; Arti Yadav; Gerard Nuovo; Pawan Kumar; Kalpana Ghoshal
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

View more
  27 in total

Review 1.  Pathogenesis of pituitary tumors.

Authors:  Shlomo Melmed
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

2.  Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway.

Authors:  T Palumbo; F R Faucz; M Azevedo; P Xekouki; D Iliopoulos; C A Stratakis
Journal:  Oncogene       Date:  2012-05-21       Impact factor: 9.867

Review 3.  Minireview: The roles of small RNA pathways in reproductive medicine.

Authors:  Shannon M Hawkins; Gregory M Buchold; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2011-05-05

Review 4.  MicroRNAs in the human pituitary.

Authors:  Milani Sivapragasam; Fabio Rotondo; Ricardo V Lloyd; Bernd W Scheithauer; Michael Cusimano; Luis V Syro; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2011-09       Impact factor: 3.943

5.  MicroRNA-200b inhibits pituitary tumor cell proliferation and invasion by targeting PKCα.

Authors:  Yuanchuan Wang; Xiaohong Yin; Long Zhao; Shun Li; Jie Duan; Renzhao Kuang; Junwei Duan
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

6.  MicroRNA involvement in a metastatic non-functioning pituitary carcinoma.

Authors:  Zhenqing Wei; Cuiqi Zhou; Mei Liu; Yong Yao; Jian Sun; Jianqi Xiao; Wenbin Ma; Huijuan Zhu; Renzhi Wang
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

Review 7.  MicroRNAs: Suggested role in pituitary adenoma pathogenesis.

Authors:  M R Gadelha; L Kasuki; J Dénes; G Trivellin; M Korbonits
Journal:  J Endocrinol Invest       Date:  2013-11       Impact factor: 4.256

8.  Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas.

Authors:  Pornsuk Cheunsuchon; Yunli Zhou; Xun Zhang; Hang Lee; Wendy Chen; Yuki Nakayama; Kimberley A Rice; E Tessa Hedley-Whyte; Brooke Swearingen; Anne Klibanski
Journal:  Am J Pathol       Date:  2011-08-24       Impact factor: 4.307

9.  In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.

Authors:  Zhenying Guo; Heather Hardin; Celina Montemayor-Garcia; Sofia Asioli; Alberto Righi; Francesca Maletta; Anna Sapino; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2015-05       Impact factor: 3.943

Review 10.  Gene expression in prolactinomas: a systematic review.

Authors:  Justin Seltzer; Thomas C Scotton; Keiko Kang; Gabriel Zada; John D Carmichael
Journal:  Pituitary       Date:  2016-02       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.